Active Not RecruitingNCT04645212
Long-term Study of ADVM-022 in Neovascular (Wet) AMD [OPTIC-EXT]
Phase not reported · 23 planned enrolment
- Countries listed
- 1
- Registry update
- February 10, 2026
Registry Intervention View
ADVM-022
Trial registrations containing the exact intervention label ADVM-022.
Exact registry label · Not reported
3 linked registrations
No aliases or equivalent products have been inferred.
Topics connected by trial metadata
0 linked registrations report posted results
This is a registry availability fact, not a safety result, comparison, or conclusion.
Understand the safety boundary →Registered trials
Active Not RecruitingNCT05536973
Safety and Efficacy of ADVM-022 in Treatment-Experienced Patients With Neovascular Age-related Macular Degeneration [LUNA]
PHASE2 · 69 planned enrolment
- Countries listed
- 3
- Registry update
- August 22, 2025
CompletedNCT03748784
ADVM-022 Intravitreal Gene Therapy for Wet AMD
PHASE1 · 30 planned enrolment
- Countries listed
- 1
- Registry update
- August 8, 2023